Thermo Fisher Extends Premaitha Loan Agreement

Close up of hands and stationery, showing business people on a calculator

Thermo Fisher Extends Premaitha Loan Agreement

Manchester-headquartered molecular diagnostics company Premaitha Health has extended its investment agreement with US group Thermo Fisher Scientific.

Under the new agreement, Thermo Fisher will provide Premaitha with an additional secured loan facility of $5m (£3.8m). The company will draw down $4m immediately to support its commercial growth strategies.

See the article in full at

Important information

This information is of a general nature and does not constitute an offer to provide services.

The opinions and conclusions given here are those of Seneca Partners and are subject to change without notice.

The value of investments and/or any income arising from them may fluctuate.

Past performance is not necessarily a guide to future performance.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.